360 related articles for article (PubMed ID: 15233723)
1. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.
Heath WR; Belz GT; Behrens GM; Smith CM; Forehan SP; Parish IA; Davey GM; Wilson NS; Carbone FR; Villadangos JA
Immunol Rev; 2004 Jun; 199():9-26. PubMed ID: 15233723
[TBL] [Abstract][Full Text] [Related]
2. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
3. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.
Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA
Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337
[TBL] [Abstract][Full Text] [Related]
4. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
5. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases.
Smyth LA; Herrera OB; Golshayan D; Lombardi G; Lechler RI
Transplantation; 2006 Jul; 82(1 Suppl):S15-8. PubMed ID: 16829787
[TBL] [Abstract][Full Text] [Related]
7. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications.
Wilson NS; Villadangos JA
Adv Immunol; 2005; 86():241-305. PubMed ID: 15705424
[TBL] [Abstract][Full Text] [Related]
8. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
9. The processing of antigens delivered as DNA vaccines.
Howarth M; Elliott T
Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
[TBL] [Abstract][Full Text] [Related]
10. CD8alpha+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor.
McDonnell AM; Prosser AC; van Bruggen I; Robinson BW; Currie AJ
Eur J Immunol; 2010 Jun; 40(6):1617-27. PubMed ID: 20373290
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
[TBL] [Abstract][Full Text] [Related]
12. Inclusion of Brefeldin A during dendritic cell isolation allows in vitro detection of cross-presented self-antigens.
Benke D; Krüger T; Lang A; Hamilton-Williams EE; Kurts C
J Immunol Methods; 2006 Mar; 310(1-2):12-9. PubMed ID: 16510151
[TBL] [Abstract][Full Text] [Related]
13. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
Neuenhahn M; Busch DH
Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.
Zehn D; Cohen CJ; Reiter Y; Walden P
Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
16. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
[TBL] [Abstract][Full Text] [Related]
17. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
Hung CF; Yang M; Wu TC
Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
[TBL] [Abstract][Full Text] [Related]
18. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus.
Belz GT; Smith CM; Kleinert L; Reading P; Brooks A; Shortman K; Carbone FR; Heath WR
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8670-5. PubMed ID: 15163797
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
20. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity.
Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B
Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
